000 03614nam a22004215i 4500
999 _c9939
_d9939
001 9939
003 DE-He213
005 20210601040350.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 171106s2018 gw | s |||| 0|eng d
020 _a9783319666792
024 7 _a10.1007/978-3-319-66679-2
_2doi
040 _bspa
_dES-VaUE
050 4 _aRC321
_b.C45 2018EB
245 1 0 _aCellular and Molecular Approaches to Regeneration and Repair
_cedited by Paul A. Lapchak, John H. Zhang.
264 1 _aCham
_bSpringer International Publishing :
_bImprint: Springer
_c2018.
300 _aVII, 541 p. 46 illus., 45 illus. in color.
_bonline resource.
336 _2rdacontent
_aTexto (visual)
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
_2rda
490 1 _aSpringer Series in Translational Stroke Research,
_x2363-958X
490 _aMedicine (Springer-11650)
520 _aThis book discusses recent advances in the field of translational stroke research. The editors have designed the book to provide new insight into the importance of regeneration and repair mechanisms for stroke victims. The editors have brought together a talented group of international stroke researchers and clinicians to contribute to this volume, which is written for students, researchers and physicians in biotechnology, neurosciences, neurology, neuroradiology and neurosurgery. Throughout the world, stroke is still a leading cause of mortality and morbidity; there are 152,000 strokes in the United Kingdom, 62,000 in Canada, and approximately 15 million people worldwide. Large communities of stroke survivors are eagerly awaiting scientific advances in translational stroke research related to regeneration and recovery of function that would offer new therapeutics for rehabilitation and regeneration utilizing novel stem cell and molecular-based approaches. This volume will allow the reader to understand the future of stroke treatment from its inception in the laboratory through to clinical trial design. The reader will learn about the recent advances made in these areas related to basic and applied stroke research and their translational potential. Dr. Paul A. Lapchak is Professor of Neurology and Director of Translational Research in the Departments of Neurology & Neurosurgery at Cedars-Sinai Medical Center in Los Angeles CA, USA. Dr. Lapchak is an internationally recognized expert conducting translational drug development research for ischemic and hemorrhagic stroke. Dr. John H. Zhang is Professor of Anesthesiology, Neurosurgery, Neurology, and Physiology, and Director, Center for Neuroscience Research at Loma Linda University School of Medicine, Loma Linda, CA, USA. Dr. Zhang is an internationally recognized expert working on drug development for hemorrhagic stroke.
653 0 _aNeurosciences.
653 0 _aNeurology.
700 1 _aLapchak, Paul A.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aZhang, John H.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_988233
710 2 _aSpringerLink (Online service)
_9106996
776 0 8 _iPrinted edition:
_z9783319666785
776 0 8 _iPrinted edition:
_z9783319666808
776 0 8 _iPrinted edition:
_z9783319882994
830 0 _aSpringer Series in Translational Stroke Research,
_x2363-958X
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-66679-2
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
998 _db